| 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of … F Mach, C Baigent, AL Catapano, KC Koskinas, M Casula, L Badimon, ... European heart journal 41 (1), 111-188, 2020 | 9901 | 2020 |
| Global epidemiology of dyslipidaemias A Pirillo, M Casula, E Olmastroni, GD Norata, AL Catapano Nature Reviews Cardiology 18 (10), 689-700, 2021 | 618 | 2021 |
| Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) AJ Vallejo-Vaz, CAT Stevens, ARM Lyons, KI Dharmayat, T Freiberger, ... The Lancet 398 (10312), 1713-1725, 2021 | 236 | 2021 |
| Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: A meta-analysis of randomized, double blind, placebo … M Casula, D Soranna, AL Catapano, G Corrao Atherosclerosis Supplements 14 (2), 243-251, 2013 | 219 | 2013 |
| Statin use and risk of new-onset diabetes: A meta-analysis of observational studies M Casula, F Mozzanica, L Scotti, E Tragni, A Pirillo, G Corrao, ... Nutrition, metabolism and cardiovascular diseases 27 (5), 396-406, 2017 | 191 | 2017 |
| Statins and the risk of diabetes: evidence from a large population-based cohort study G Corrao, B Ibrahim, F Nicotra, D Soranna, L Merlino, AL Catapano, ... Diabetes care 37 (8), 2225-2232, 2014 | 131 | 2014 |
| Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study TR Tromp, ML Hartgers, GK Hovingh, AJ Vallejo-Vaz, KK Ray, H Soran, ... The Lancet 399 (10326), 719-728, 2022 | 126 | 2022 |
| Statin use and risk of dementia or Alzheimer’s disease: a systematic review and meta-analysis of observational studies E Olmastroni, G Molari, N De Beni, O Colpani, F Galimberti, M Gazzotti, ... European journal of preventive cardiology 29 (5), 804-814, 2022 | 120 | 2022 |
| HDL in atherosclerotic cardiovascular disease: in search of a role M Casula, O Colpani, S Xie, AL Catapano, A Baragetti Cells 10 (8), 1869, 2021 | 96 | 2021 |
| Prevalence of the prescription of potentially interacting drugs E Tragni, M Casula, V Pieri, G Favato, A Marcobelli, MG Trotta, ... Plos one 8 (10), e78827, 2013 | 91 | 2013 |
| Spectrum of mutations in Italian patients with familial hypercholesterolemia: new results from the LIPIGEN study A Pirillo, K Garlaschelli, M Arca, M Averna, S Bertolini, S Calandra, ... Atherosclerosis Supplements 29, 17-24, 2017 | 83 | 2017 |
| Familial hypercholesterolemia: the Italian atherosclerosis society network (LIPIGEN) M Averna, AB Cefalu, M Casula, D Noto, M Arca, S Bertolini, S Calandra, ... Atherosclerosis Supplements 29, 11-16, 2017 | 80 | 2017 |
| Adherence to lipid-lowering treatment: the patient perspective M Casula, E Tragni, AL Catapano Patient preference and adherence, 805-814, 2012 | 79 | 2012 |
| Scientific Document Group. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk F Mach, C Baigent, AL Catapano, KC Koskinas, M Casula, L Badimon, ... Eur Heart J 41 (1), 111-188, 2020 | 71 | 2020 |
| Are generic and brand-name statins clinically equivalent? Evidence from a real data-base G Corrao, D Soranna, A Arfè, M Casula, E Tragni, L Merlino, G Mancia, ... European journal of internal medicine 25 (8), 745-750, 2014 | 66 | 2014 |
| Guía ESC/EAS 2019 sobre el tratamiento de las dislipemias: modificación de los lípidos para reducir el riesgo cardiovascular F Mach, C Baigent, AL Catapano, KC Koskinas, M Casula, LB Maestro, ... Revista española de cardiología 73 (5), 403-403, 2020 | 60 | 2020 |
| Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study M Casula, E Olmastroni, A Pirillo, AL Catapano, M Arca, M Averna, ... Atherosclerosis 277, 413-418, 2018 | 55 | 2018 |
| Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of … M Casula, E Olmastroni, M Gazzotti, F Galimberti, A Zambon, ... Pharmacological Research 160, 105060, 2020 | 53 | 2020 |
| ESC Scientific Document Group. 2019 ESC F Mach, C Baigent, AL Catapano, KC Koskinas, M Casula, L Badimon, ... EAS Guidelines for the management of dyslipidaemias: lipid modification to …, 2020 | 51 | 2020 |
| Cardiovascular events with PCSK9 inhibitors: an updated meta-analysis of randomised controlled trials M Casula, E Olmastroni, MT Boccalari, E Tragni, A Pirillo, AL Catapano Pharmacological research 143, 143-150, 2019 | 45 | 2019 |
